Drug data last refreshed 15h ago · AI intelligence enriched 2w ago
VOLTAREN is an oral delayed-release tablet containing diclofenac, a nonsteroidal anti-inflammatory drug (NSAID) approved in 1988. It is used to treat pain, inflammation, and related conditions across multiple indications. The drug works by inhibiting cyclooxygenase enzymes to reduce prostaglandin synthesis.
This mature product faces approaching loss of exclusivity with moderate competitive pressure (30), indicating a contracting brand team and focus on managed decline or repositioning strategies.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
To Evaluate the Superiority of Fixed Combination (Orfenadrine 35mg, Acetaminophen 325mg, Caffeine 65mg and Diclofenac Sodium 50mg) Compared to Voltaren® (Diclofenac Sodium 50mg) in the Treatment of Acute Postural Low Back Pain.
Voltaren Emulgel 2% Acute Ankle Sprain Non Inferiority Study
Comparison of Treatment With Preservative-free Dexamethasone 0.1% (Monofree Dexamethason) and Diclofenac 0.1% (Dicloabak) Eye Drops Versus Preserved Dexamethasone 0.1% (Maxidex) and Diclofenac 0.1% (Voltaren Ophtha) Eye Drops After Cataract Surgery
Pharmacokinetics Study Comparing Topical Diclofenac/Menthol Gels With Voltaren Gel and Oral Diclofenac Sodium
An Investigator Initiated, Within-Subject, Proof of Concept Study to Assess the Efficacy and Safety of Voltaren Gel in Subjects With DOMS
Worked on VOLTAREN at Novartis? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Working on VOLTAREN offers limited growth opportunities given its mature lifecycle and approaching loss of exclusivity, making it suited for professionals seeking to manage established portfolios or transition to other products. Positions tend to focus on operational efficiency, managed care strategy, and compliance rather than innovation or market expansion.